Business registries · firm from USPTO records
Vertex Pharmaceuticals Incorporated
USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.
- Place
- 50 Northern Avenue, Boston, MA
- Entity type
- Corporation
- State of organization
- MA (as the owner states it in trademark filings)
- Patents
- 745 granted 1989-11-14 to 2025-12-30
- Trademarks
- 122, 69 live
- Record
- EXACT high confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12766094 | Cell housing device | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12673952 | Processes for preparing modulators of alpha-1 antitrypsin | 2026-07-07 | PTBLXML, file of 2026-07-07 |
| US 12662471 | 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12662470 | Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channels | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12653860 | Compositions and methods for editing beta-globin for treatment of hemaglobinopathies | 2026-06-16 | PTBLXML, file of 2026-06-16 |
| US 12644137 | Materials and methods for treatment of hemoglobinopathies | 2026-06-02 | PTBLXML, file of 2026-06-02 |
| US 12637661 | Methods of enhancing stem cell differentiation into beta cells | 2026-05-26 | PTBLXML, file of 2026-05-26 |
| US 12629376 | Composition for use in the treatment of ApoL1-associated disease | 2026-05-19 | PTBLXML, file of 2026-05-19 |
| US 12624028 | 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | 2026-05-12 | PTBLXML, file of 2026-05-12 |
| US 12612416 | Modulators of cystic fibrosis transmembrane conductance regulator | 2026-04-28 | PTBLXML, file of 2026-04-28 |
| US 12612379 | Inhibitors of APOL1 and methods of using same | 2026-04-28 | PTBLXML, file of 2026-04-28 |
| US 12577233 | Solid forms of APOL1 inhibitor and methods of using same | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12552810 | Crystalline forms of CFTR modulators | 2026-02-17 | PTBLXML, file of 2026-02-17 |
| US 12544545 | Macroencapsulation devices | 2026-02-10 | PTBLXML, file of 2026-02-10 |
| US 12515028 | Multicompartment macroencapsulation devices | 2026-01-06 | PTBLXML, file of 2026-02-13 |
| US 12508231 | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | 2025-12-30 | PVGPATDIS, file of 2026-04-10 |
| US 12503439 | Heteroaryl compounds for the treatment of pain | 2025-12-23 | PVGPATDIS, file of 2026-04-10 |
| US 12502376 | Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | 2025-12-23 | PVGPATDIS, file of 2026-04-10 |
| US 12497614 | Compositions and methods for editing beta-globin for treatment of hemaglobinopathies | 2025-12-16 | PVGPATDIS, file of 2026-04-10 |
| US 12492388 | Materials and methods for treatment of hemoglobinopathies | 2025-12-09 | PVGPATDIS, file of 2026-04-10 |
| US 12458635 | Pharmaceutical composition and administrations thereof | 2025-11-04 | PVGPATDIS, file of 2026-04-10 |
| US 12442020 | Materials and methods for treatment of pain related disorders | 2025-10-14 | PVGPATDIS, file of 2026-04-10 |
| US 12441703 | Carboxamides as modulators of sodium channels | 2025-10-14 | PVGPATDIS, file of 2026-04-10 |
| US 12440481 | Esters and carbamates as modulators of sodium channels | 2025-10-14 | PVGPATDIS, file of 2026-04-10 |
| US 12421251 | Cystic fibrosis transmembrane conductance regulator modulating agents | 2025-09-23 | PVGPATDIS, file of 2026-04-10 |
The newest 25 of 745. All patents of this assignee
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| YURPOVI | 50163259 | 2026-10-15 | Pending application | 005 | TRTDXFAP, file of 2026-10-16 |
| UPOBA | 50163254 | 2026-10-15 | Pending application | 005 | TRTDXFAP, file of 2026-10-16 |
| BELMODICO | 50163251 | 2026-10-15 | Pending application | 005 | TRTDXFAP, file of 2026-10-16 |
| BAMPOVIOS | 50163241 | 2026-10-15 | Pending application | 005 | TRTDXFAP, file of 2026-10-16 |
| AMPOZEOS | 50163235 | 2026-10-15 | Pending application | 005 | TRTDXFAP, file of 2026-10-16 |
| THE POVTENZI TRIFECTA | 50073326 | 2026-08-26 | Pending application | 044 | TRTDXFAP, file of 2026-08-27 |
| POVTENZI + YOU | 99799399 | 2026-05-01 | Pending application | 044 | TRTDXFAP, file of 2026-10-22 |
| POVTENZI | 99779444 | 2026-04-22 | Pending application | 005 | TRTDXFAP, file of 2026-09-30 |
| POVTENZI | 99714539 | 2026-03-20 | Pending application | 005 | TRTDXFAP, file of 2026-09-09 |
| VYKAFTY | 99685511 | 2026-03-05 | Pending application | 005 | TRTDXFAP, file of 2026-09-30 |
| INFORMEDPAINCARE | 99560709 | 2025-12-22 | Pending application | 044 | TRTDXFAP, file of 2026-08-08 |
| INFORMED PAIN CARE | 99553291 | 2025-12-17 | Pending application | 044 | TRTDXFAP, file of 2026-09-01 |
| (design) | 99518171 | 2025-11-26 | Pending application | 005 | TRTDXFAP, file of 2026-07-15 |
| (design) | 99518157 | 2025-11-26 | Pending application | 005 | TRTDXFAP, file of 2026-08-12 |
| DONDE EMPIEZA EL DOLOR COMIENZA JOURNAVX | 99377064 | 2025-09-05 | Pending application | 035, 044 | TRTDXFAP, file of 2026-10-11 |
| ISLEKEY | 99376563 | 2025-09-05 | Pending application | 005 | TRTDXFAP, file of 2026-09-17 |
| HABLEMOS SOBRE EL DOLOR | 99376556 | 2025-09-05 | Pending application | 044 | TRTDXFAP, file of 2026-10-11 |
| TALK ABOUT PAIN LIVE | 99376550 | 2025-09-05 | Registered | 044 | TRTDXFAP, file of 2026-09-30 |
| NAVIGATING PAIN PATHWAYS | 99376538 | 2025-09-05 | Pending application | 044 | TRTDXFAP, file of 2026-07-02 |
| AMPOVIOS | 99250876 | 2025-06-24 | Pending application | 005 | TRTDXFAP, file of 2026-10-06 |
| BYPOVY | 99250874 | 2025-06-24 | Pending application | 005 | TRTDXFAP, file of 2026-10-06 |
| POVTENZI | 99250865 | 2025-06-24 | Pending application | 005 | TRTDXFAP, file of 2026-10-06 |
| MYTDTFUTURE | 99187713 | 2025-05-15 | Registered | 044 | TRTDXFAP, file of 2026-08-05 |
| TODAY DETERMINES TOMORROW | 99187709 | 2025-05-15 | Registered | 044 | TRTDXFAP, file of 2026-05-27 |
| POWER FORWARD | 99166138 | 2025-05-01 | Registered | 044 | TRTYRAP, file of 2026-04-03 |
The newest 25 of 122. All marks of this owner
Possible related entities
- Vertex Pharmaceuticals (Distribution) Incorporated CO business registration FUZZY same street address as a state registration
- VERTEX PHARMACEUTICALS (DISTRIBUTION) INCORPORATED FL business registration FUZZY same street address as a state registration
- VERTEX PHARMACEUTICALS (DISTRIBUTION) INCORPORATED OR business registration FUZZY same street address as a state registration
- VERTEX PHARMACEUTICALS, INC. FL business registration FUZZY same street address as a state registration
- Leap OpCo, Inc. firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- VIVIDBIO OPCO, INC. firm from USPTO records, 2 trademarks FUZZY same street address (trademark filings)
- Vivid Biosciences, LLC firm from USPTO records, 3 trademarks FUZZY same street address (trademark filings)
Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.